LAGOS, Oct. 1 (Reuters) – Nigeria on Friday obtained approval for $ 400 million in funding from the World Bank to procure and deploy COVID-19 vaccines, the bank said in a statement.
The World Bank’s board has approved the funding, provided through the International Development Association, which it says would allow Africa’s most populous country to purchase COVID-19 vaccines for 40 million people, or about 18% of its population, and to support the deployment of vaccines. to 110 million people.
In a statement, the bank said the money would ensure the government can immunize 51% of its population within two years and “avoid the dire consequences of yet another lockdown that has left in its wake an economic toll with which the country is still struggling “.
Last month, the government said about 20% of Nigerian workers lost their jobs due to COVID-19. Read more
Nigeria has administered some five million doses of vaccine to its 200 million citizens and is in the process of rolling out millions of additional doses of Moderna and AstraZeneca vaccines received through the COVAX program to provide vaccines to developing countries.
He also has 1.12 million doses of the Johnson & Johnson vaccine (JNJ.N) which he purchased as part of an African Union program and is also expected to receive 7.7 million doses of the Sinopharm vaccine via COVAX. Read more
As of October 1, Nigeria had recorded 205,779 confirmed cases of COVID-19 and 2,721 deaths from the virus.
Reporting by Libby George in Lagos and Camillus Eboh in Abuja, editing by Nick Zieminski
Our Standards: The Thomson Reuters Trust Principles.